By Scientia Professor Gregory John Dore

Journal articles

Pett SL; Dore GJ; Fielden R; Cooper DA, 2002, 'Cyclical hepatitis and early liver cirrhosis after hepatitis C seroconversion during pulsed antiretroviral therapy for primary HIV-1', AIDS, 16, pp. 2364 - 2365

McDonald AM; Dore GJ; Grulich AE; Law MG; Prestage G; Smith DE, 2002, 'Epidemiological and social research finds at the 14th International AIDS Conference', Australian HIV Surveillance Report, 18, pp. 1 - 8

Danta M; Dore GJ; Hennessy L; Li Y; Vickers CR; Harley H; Ngu M; Reed W; Desmond PV; Sievert W; Farrell G; Kaldor JM; Batey RG, 2002, 'Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection', Medical Journal of Australia, 177, pp. 240 - 245

Dore GJ; Li Y; McDonald AM; Ree H; Kaldor JM, 2002, 'Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 29, pp. 388 - 395

Talawat S; Dore GJ; Le Coeur S; Lallemant M, 2002, 'Infant feeding practices and attitudes among women with HIV infection in northern Thailand', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 14, pp. 625 - 631

Spencer J; Dore GJ; Robotin M; Correll PK; Kaldor JM, 2002, 'Outcomes from the first two years of the Australian Hepatitis surveillance strategy', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 26, pp. 14 - 22

Law MG; Dore GJ; Kaldor JM, 2001, 'Projecting severe sequelae of injection-related hepatitis C virus epidemic in UK by SM Bird, DJ Goldberg and SJ Hutchinson', Journal of Epidemiology and Biostatistics, 6, pp. 279 - 281, http://dx.doi.org/10.1080/135952201317080689

Dore GJ; Cooper DA, 2001, 'Bridging the divide: Global inequities in access to HIV/AIDS therapy', Medical Journal of Australia, 175, pp. 570 - 572, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143729.x

Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2001, 'Estimating progression to cirrhosis in chronic hepatitis C virus infection', Hepatology, 34, pp. 809 - 816, http://dx.doi.org/10.1053/jhep.2001.27831

Dore GJ; Li Y; McDonald AM; Kaldor JM, 2001, 'Spectrum of AIDS-defining illnesses in Australia, 1992 to 1998: Influence of country/region of birth', JAIDS: Journal of Acquired Immune Deficiency Syndromes, pp. 283 - 290

Dore GJ; Cooper DA, 2001, 'The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses', Current Opinion in Infectious Diseases, 14, pp. 749 - 755

Dore GJ; Kaldor JM, 2000, 'Detection of HCV RNA in semen', LANCET, 356, pp. 1520 - 1520, http://dx.doi.org/10.1016/S0140-6736(00)02890-7

Dore GJ; Kaldor JM; Leruez-Ville M; Rouzioux C; Chaix ML, 2000, 'Detection of HCV RNA in semen [1] (multiple letters)', Lancet, 356, pp. 1520, http://dx.doi.org/10.1016/S0140-6736(00)02890-7

Li Y; McDonald AM; Dore GJ; Kaldor JM, 2000, 'Improving survival following AIDS in Australia, 1991-1996. National HIV Surveillance Committee.', AIDS, 14, pp. 2349 - 2354, http://dx.doi.org/10.1097/00002030-200010200-00016

Law MG; Roberts SK; Dore GJ; Kaldor JM, 2000, 'Primary hepatocellular carcinoma in Australia, 1978-1997: Increasing incidence and mortality', Medical Journal of Australia, 173, pp. 403 - 405, http://dx.doi.org/10.5694/j.1326-5377.2000.tb139267.x

Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2000, 'The natural history of chronic hepatitis C: A systematic review', HEPATOLOGY, 32, pp. 422A - 422A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622401038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guthrie JA; Dore GJ; McDonald AM; Kaldor JM, 2000, 'HIV and AIDS in aboriginal and Torres Strait Islander Australians: 1992-1998. The National HIV Surveillance Committee.', Med J Aust, 172, pp. 266 - 269, https://www.ncbi.nlm.nih.gov/pubmed/10860091

Kaldor JM; Dore GJ; Correll PKL, 2000, 'Public health challenges in hepatitis C virus infection', Journal of Gastroenterology and Hepatology Australia, 15, pp. E83 - E90, http://dx.doi.org/10.1046/j.1440-1746.2000.02134.x

Wilkinson DL; Dore GJ, 2000, 'An unbridgeable gap? Comparing the HIV/AIDS epidemics in Australia and sub-Saharan Africa', Australian and New Zealand Journal of Public Health, pp. 276 - 280

Brew BJ; Dore GJ, 2000, 'Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapy (letter)', Neurology, pp. 1424 - 1424

Dore GJ; Kaldor JM, 2000, 'Detection of HCV RNA in semen (letter)', Lancet, pp. 1520 - 1520

Dore GJ; Grulich AE; Prestage G, 2000, 'Epidemiological and social research findings reported at the 13th World AIDS Conference', Australian HIV Surveillance Report, 16, pp. 1 - 6

Guthrie J; Dore GJ; McDonald AM; Kaldor JM; For TNHS, 2000, 'HIV and AIDS in Aboriginal and Torres Strait Islander Australians:1992-1998', Medical Journal of Australia, 172, pp. 266 - 269

Grulich AE; Dore GJ; Brew BJ, 2000, 'Human herpesvirus 8 and protection from AIDS dementia complex', Herpes, pp. 38 - 40

Li Y; McDonald AM; Dore GJ; Kaldor JM; For TNHS, 2000, 'Improving survival following AIDS in Australia, 1991-1996', AIDS, 14, pp. 2349 - 2354

Dore GJ, 2000, 'Infectious diseases in the 21st century: are we entering the hot-zone?', Australian Family Physician, pp. 627 - 630

Dore GJ; Brew BJ, 2000, 'Response to Eberly et al., Kaposi¿s sarcoma and central nervous system disease: a real association or an artifact of the control group? (letter)', AIDS, 14, pp. 2631 - 2632

Dore GJ, 2000, 'Sexual transmission of hepatitis C: what is the evidence?', Australian Hepatitis Chronicle, pp. 2 - 5

Kaldor JM; Dore GJ; Correll PK, 2000, 'Towards control of hepatitis C in the Asia-Pacific region ¿ Public health challenges in hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 15, pp. E83 - E90

Lurie P; Wolfe SM; McNeill PM; Dore GJ, 1999, 'Should research ethics change at the border? (multiple letters) [6]', Medical Journal of Australia, 171, pp. 167 - 168, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123586.x

Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ, 1999, 'Changes to AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 13, pp. 1249 - 1253

Dore GJ; Cooper DA; Barrett C; Goh L; Thakrar B; Atkins M, 1999, 'Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR)', Journal of Infectious Diseases, 180, pp. 607 - 613

Dore GJ; Law MG; Kaldor JM, 1999, 'Prevalence of hepatitis C virus infection in the United States', New England Journal of Medicine, pp. 2093 - 2094 (lett

Mcneil PM; Dore GJ, 1999, 'Should research ethics change at the border?', Medical Journal of Australia, 171, pp. 168 - (letter)

Dore GJ; Pritchard-Jones J; Fisher D; Law MG, 1999, 'Who's at risk: risk factors for HCV infection in Australia', Australian Family Physician, pp. 8 - 13

Dore GJ; Grulich A; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi's sarcoma and protection from AIDS dementia complex [4]', AIDS, 12, pp. 2354 - 2355

Wettstein AR; Dore G; Murphy C; Edwards PD, 1998, 'HIV related cholangiopathy (HIVRC): Is endoscopic biliary sphincterotomy (EBS) an effective therapy?', Gastrointestinal Endoscopy, 47, pp. AB132

McNeill PM, 1998, 'Should research ethics change at the border?', Medical Journal of Australia, 169, pp. 509 - 510, http://dx.doi.org/10.5694/j.1326-5377.1998.tb123394.x

Collignon P; Dore GJ; Li Y; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates (multiple letters) [3]', Medical Journal of Australia, 169, pp. 444 - 448, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126845.x

Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C - Summary vertical transmission rates may be misleading - Reply', BMJ-BRITISH MEDICAL JOURNAL, 316, pp. 554 - 554

Thomas S; Hall A; Newell ML; Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C (multiple letters) [5]', British Medical Journal, 316, pp. 553 - 554

Hira SK; Dore GJ; Sirisanthana T, 1998, 'Clinical spectrum of HIV/AIDS in the Asia-Pacific region.', AIDS London England, 12 Suppl B, pp. S145 - S154

Dore GJ, 1998, 'Chronic hepatitis C infection: a disease ideally suited to management in the primary care setting', Australian Family Physician, pp. 791 - 793

McDonald AM; French R; Dore GJ; Hamernik E; Kippax SC; Ashton LJ, 1998, 'Epidemiological and social research findings reported at the 12th World AIDS Conference, Geneva 1998', Australian HIV Surveillance Report, 14, pp. 1 - 9

Crofts JN; Dore GJ; Kaldor JM; Law MG; Wodak AD; Et A, 1998, 'Estimates and projections of the hepatitis C virus epidemic in Australia', ION Meeting Proceedings

Dore GJ; Brown TA; Tarantola D; Kaldor JM, 1998, 'HIV and AIDS in the Asia-Pacific region: an epidemiological overview', AIDS, 12, pp. S1 - S10

Van Beek IA; Dwyer RG; Dore GJ; Luo K; Kaldor JM, 1998, 'Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study', British Medical Journal: International, pp. 433 - 437

Dore GJ; Kaldor JM; Mccaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C', British Medical Journal: International, pp. 553 - 554

Dore GJ, 1998, 'Report from the 4th International Conference on AIDS in Asia and the Pacific', Noah's Arc

Dore GJ; Kaldor JM, 1998, 'Sexually transmissible diseases surveillance in Australia: towards a coordinated national system', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, pp. 49 - 52

Back to profile page